David Ahn, M.D. | Source | Chief of Diabetes Services at Hoag Health System
David Ahn, M.D.
David Ahn, M.D. is an Endocrinologist, Program Director, and Kris V. Iyer Endowed Chair in Diabetes Care at the Mary and Dick Allen Diabetes Center in Newport Beach, CA. He previously was an Assistant Clinical Professor at UCLA. Born and raised in Southern California, Dr. Ahn received his Medical Degree and completed a fellowship in Endocrinology at UC San Diego.
He is passionate about empowering people with type 1 diabetes, type 2 diabetes, pre-diabetes and gestational diabetes to optimize their blood sugar control while minimizing the emotional burden of living with chronic disease. He has an interest in diabetes technology, including continuous glucose monitors, insulin pumps and smartphone apps.
-
Hoag Health System
Chief of Diabetes Services
-
What I Wish Everyone Understood About Type 1 Diabetes
The idea that type 1 diabetics “did something wrong” to cause their disease may sound ridiculous to those who know it’s an autoimmune disorder. But because the vast majority of people equate all diabetes with type 2 diabetes (and even then, neglect to consider non-lifestyle factors behind that condition; there is no “moral” or “immoral” type of diabetes) these misconceptions persist. According to a 2017 study from Clinical Diabetes, as many as 76% of type 1 diabetics report experiencing stigma. “This can be extremely offensive,” says David Ahn, MD, a board-certified endocrinologist and chief of diabetes at Hoag Hospital in Newport Beach, California. “One of the worst feelings in general is to be wrongly accused of something you didn’t do. The fact that this misunderstanding is regarding a lifelong chronic disease without a cure only makes it worse.”
Article -
Biggest Diabetes Tech Announcements - ATTD 2025
Endocrinologist David Ahn and I break down the biggest diabetes tech announcements from the ATTD conference in Amsterdam!
Article -
Continuous Glucose Monitoring: For Insulin Users and Beyond
David T. Ahn, MD, chief of Diabetes Services at Hoag Memorial Hospital Presbyterian, Newport Beach, California, told Medscape Medical News that he offers CGM to all his patients with T2D but that those who accept “tend to self-select for those that are interested in harnessing the data and ‘learning about their body’…Many people who are not on insulin may not require long-term, continuous usage of CGM, and instead may stop using it after an initial 6- to 12-week learning period or transition over to an intermittent use scenario.”
Article
